Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Baltimore, MD
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Germantown, TN
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Stage III Unresectable or Stage IV Advanced Melanoma Clinical Trial
Expanded Access Program With Nivolumab for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti_CTLA-4 Monoclonal Antibody (CheckMate 168)
Status: Enrolling
Updated: 12/18/2014
mi
from
Mobile, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 6/15/2015
mi
from
Rochester, MN
Click here to add this to my saved trials
Unresectable or Metastatic Melanoma Clinical Trial
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Status: Enrolling, Phase III
Updated: 2/26/2014
mi
from
San Francisco, CA
Click here to add this to my saved trials
Unresectable or Metastatic Melanoma Clinical Trial
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Status: Enrolling, Phase III
Updated: 2/26/2014
mi
from
Latham, NY
Click here to add this to my saved trials
Unresectable or Metastatic Melanoma Clinical Trial
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Status: Enrolling, Phase III
Updated: 2/26/2014
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Buffalo, NY
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Green Bay, WI
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Omaha, NE
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Rochester, MN
Click here to add this to my saved trials
Melanoma Clinical Trial
LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
Status: Enrolling, Phase II
Updated: 7/29/2014
mi
from
Dallas, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
Status: Enrolling, Phase II
Updated: 7/29/2014
mi
from
New York, NY
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/28/2014
mi
from
Durham, NC
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/28/2014
mi
from
Iowa City, IA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/28/2014
mi
from
La Jolla, CA
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma
Status: Enrolling, Phase IV
Updated: 5/28/2014
mi
from
Tucson, AZ
Click here to add this to my saved trials
Melanoma Clinical Trial
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
Status: Enrolling, Phase III
Updated: 11/20/2015
mi
from
Beverly HIlls, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Multiple Antigen-Engineered DC Vaccine for Melanoma
Status: Enrolling, Phase I
Updated: 5/27/2015
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC and Melanoma
Status: Enrolling, Phase I, II
Updated: 12/23/2015
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
Status: Enrolling, Phase II
Updated: 12/3/2015
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase IIB TL + YCWP + DC in Melanoma
Status: Enrolling, Phase II
Updated: 12/8/2015
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase IIB TL + YCWP + DC in Melanoma
Status: Enrolling, Phase II
Updated: 12/8/2015
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Melanoma Clinical Trial
Phase IIB TL + YCWP + DC in Melanoma
Status: Enrolling, Phase II
Updated: 12/8/2015
mi
from
South Bend, IN
Click here to add this to my saved trials
Oncology Clinical Trial
MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling
Updated: 11/16/2015
mi
from
Rochester, MN
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma
Status: Enrolling, Phase I
Updated: 8/11/2015
mi
from
Portland, OR
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of Intratumoral CAVATAK™ (Coxsackievirus A21) and Ipilimumab in Patients With Advanced Melanoma
Status: Enrolling, Phase I
Updated: 8/11/2015
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1b Safety Study of CMB305 (Sequentially Administered LV305 and G305) in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Status: Enrolling, Phase I
Updated: 12/10/2015
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
Status: Enrolling
Updated: 11/24/2015
mi
from
Gainesville, FL
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma
Status: Enrolling, Phase I
Updated: 12/8/2015
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Melanoma Clinical Trial
Digital vs. Printed Photographs: Impact on Skin Self-Examinations
Status: Enrolling
Updated: 8/7/2015
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Melanoma Clinical Trial
S1320: Intermittent Versus Continuous Dosing of Dabrafenib and Trametinib in BRAFV600E/K Mutant Melanoma
Status: Enrolling, Phase II
Updated: 7/23/2014
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 11/3/2015
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 11/3/2015
mi
from
Lebanon, NH
Click here to add this to my saved trials
Melanoma Clinical Trial
Intratumoral Injections of LL37 for Melanoma
Status: Enrolling, Phase I, II
Updated: 12/7/2015
mi
from
Houston, TX
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 11/12/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 1/28/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 1/28/2016
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 1/28/2016
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 1/28/2016
mi
from
Adrian, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 1/28/2016
mi
from
Peoria, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 1/28/2016
mi
from
Woodbury, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 2/11/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Status: Enrolling, Phase II
Updated: 2/18/2016
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Status: Enrolling, Phase II
Updated: 2/18/2016
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Status: Enrolling, Phase II
Updated: 2/18/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 3/16/2016
mi
from
Zanesville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Choroidal Melanoma Clinical Trial
Study Of Surgical Radiation Shielding With Vitrectomy And Silicone Oil Tamponade For The Protection Of Radiation Induced Ocular Injury
Status: Enrolling, Phase I
Updated: 1/4/2016
mi
from
Aurora, CO
Click here to add this to my saved trials
Melanoma Clinical Trial
Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma
Status: Enrolling, Phase I
Updated: 1/4/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins
Status: Enrolling
Updated: 1/4/2016
mi
from
West Harrison, NY
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
Status: Enrolling, Phase III
Updated: 1/6/2016
mi
from
Hershey, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 1/7/2016
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology Clinical Trial
Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions
Status: Enrolling, Phase
Updated: 1/8/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases
Status: Enrolling
Updated: 1/8/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Skin Cancer Clinical Trial
Patient Satisfaction in Cutaneous Surgery
Status: Enrolling
Updated: 1/11/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
Melanoma Clinical Trial
Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
Status: Enrolling, Phase I
Updated: 1/12/2016
mi
from
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Status: Enrolling
Updated: 1/16/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Melanoma Clinical Trial
Dendritic Cell Activating Scaffold in Melanoma
Status: Enrolling, Phase I
Updated: 1/19/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Basal Cell Carcinoma Clinical Trial
Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes
Status: Enrolling, Phase II
Updated: 1/20/2016
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 1/20/2016
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 1/20/2016
mi
from
Portland, OR
Click here to add this to my saved trials
High Risk Melanoma Clinical Trial
A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma
Status: Enrolling, Phase I
Updated: 1/20/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Melanoma Clinical Trial
The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma
Status: Enrolling, Phase II
Updated: 1/21/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
An Observational Study to Compare the Compliance With Toxicity of Standard High-Dose Interferon A Versus Sylatron
Status: Enrolling
Updated: 1/21/2016
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Melanoma and Brain Metastases Clinical Trial
Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites
Status: Enrolling, Phase II
Updated: 1/21/2016
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Melanoma, Ocular Clinical Trial
Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
Melanoma, Ocular Clinical Trial
Percutaneous Hepatic Perfusion vs Best Alternative Care in Patients With Hepatic-dominant Ocular Melanoma
Status: Enrolling, Phase III
Updated: 2/5/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Status: Enrolling
Updated: 2/16/2016
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
RTA 408 Capsules in Patients With Melanoma - REVEAL
Status: Enrolling, Phase I, II
Updated: 2/22/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Oncology Clinical Trial
Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Status: Enrolling
Updated: 2/23/2016
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
Status: Enrolling, Phase II
Updated: 2/24/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Study of RXDX-105 (RET and BRAF Inhibitor) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 2/25/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 2/26/2016
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 2/26/2016
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Advanced Uveal Melanoma
Status: Enrolling, Phase II
Updated: 3/2/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Skin Cancer Clinical Trial
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
Status: Enrolling
Updated: 3/7/2016
mi
from
New York, NY
Click here to add this to my saved trials
Carcinoma, Basal Cell Clinical Trial
VISmodegib for ORbital and Periocular Basal Cell Carcinoma
Status: Enrolling, Phase IV
Updated: 3/8/2016
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
Status: Enrolling, Phase II
Updated: 3/8/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
Status: Enrolling, Phase II
Updated: 3/11/2016
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
Status: Enrolling, Phase II
Updated: 3/11/2016
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Kinston, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Bellflower, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Bemidji, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Bismarck, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Dodge City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Fontana, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Galesburg, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Lawrence, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
San Marcos, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling, Phase II, III
Updated: 3/14/2016
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 66